학술논문
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy
Document Type
Article
Author
Source
In: Breast . (Breast, October 2023, 71:113-121)
Subject
Language
English
ISSN
15323080
09609776
09609776